Molecular genetic analysis of oligodendroglial tumors for alterations of the CDKN2A and CDKN2B tumor suppressor genes

被引：0
|
作者：
Wolter, M
Reifenberger, J
Ichimura, K
Schmidt, EE
Collins, VP
Reifenberger, G
机构：
来源：
BRAIN PATHOLOGY | 2000年 / 10卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：570 / 571
页数：2
相关论文
共 50 条
  • [31] B-cell receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter transformation
    Chakraborty, Supriya
    Martines, Claudio
    Porro, Fabiola
    Fortunati, Ilaria
    Bonato, Alice
    Dimishkovska, Marija
    Piazza, Silvano
    Yadav, Brijesh S.
    Innocenti, Idanna
    Fazio, Rosa
    Vaisitti, Tiziana
    Deaglio, Silvia
    Zamo, Alberto
    Dimovski, Aleksandar J.
    Laurenti, Luca
    Efremov, Dimitar G.
    BLOOD, 2021, 138 (12) : 1053 - 1066
  • [32] Genetic alterations of gastrinomas:: An analysis of p16INK4A/CDKN2A tumor suppressor gene.
    Serrano, J
    Goebel, S
    Jensen, RT
    GASTROENTEROLOGY, 1999, 116 (04) : A501 - A501
  • [33] Strong association of common variants in the CDKN2A/CDKN2B region with type 2 diabetes in French Europids
    K. Duesing
    G. Fatemifar
    G. Charpentier
    M. Marre
    J. Tichet
    S. Hercberg
    B. Balkau
    P. Froguel
    F. Gibson
    Diabetologia, 2008, 51 : 821 - 826
  • [34] Cellular senescence molecules expression in type 2 diabetes mellitus: CDKN2A, CDKN2B, and lncRNA ANRIL
    Anaraki, Soheila
    Kheirandish, Masoumeh
    Mousavi, Pegah
    Tamandegani, Atefe Ebrahimi
    Mohammadi, Samane
    Shekari, Mohammad
    GENE, 2024, 911
  • [35] PROGNOSTIC VALUE OF DELETIONS AND PROMOTER METHYLATION OF CDKN2A AND CDKN2B IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
    Braun, M.
    Pastorczak, A.
    Madzio, J.
    Taha, J.
    Ramiszewska, M.
    Matysiak, M.
    Derwich, K.
    Lejman, M.
    Kowalczyk, J.
    Badowska, W.
    Kazanowska, B.
    Szczepanski, T.
    Styczynski, J.
    Trelinska, J.
    Zalewska-Szewczyk, B.
    Irga-Jaworska, N.
    Mlynarski, W.
    HAEMATOLOGICA, 2015, 100 : 340 - 340
  • [36] Strong association of common variants in the CDKN2A/CDKN2B region with type 2 diabetes in French Europids
    Duesing, K.
    Fatemifar, G.
    Charpentier, G.
    Marre, M.
    Tichet, J.
    Hercberg, S.
    Balkau, B.
    Froguel, P.
    Gibson, F.
    DIABETOLOGIA, 2008, 51 (05) : 821 - 826
  • [37] Germline hemizygous deletion of CDKN2A–CDKN2B locus in a patient presenting with Li–Fraumeni syndrome
    Sock Hoai Chan
    Weng Khong Lim
    Scott T Michalski
    Jing Quan Lim
    Nur Diana Binte Ishak
    Marie Met-Domestici
    Cedric Ng Chuan Young
    Karen Vikstrom
    Edward D Esplin
    Jennifer Fulbright
    Mei Kim Ang
    Joseph Wee
    Kesavan Sittampalam
    Mohamad Farid
    Stephen E Lincoln
    Koji Itahana
    Syafiq Abdullah
    Bin Tean Teh
    Joanne Ngeow
    npj Genomic Medicine, 1
  • [38] Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets
    Walker, GJ
    Flores, JF
    Glendening, JM
    Lin, AHT
    Markl, IDC
    Fountain, JW
    GENES CHROMOSOMES & CANCER, 1998, 22 (02): : 157 - 163
  • [39] CDKN2A, CDKN2B and p14ARF are frequently and differentially methylated in ependymal tumours
    Rousseau, E
    Ruchoux, MM
    Scaravilli, F
    Chapon, F
    Vinchon, M
    De Smet, C
    Godfraind, C
    Vikkula, M
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2003, 29 (06) : 574 - 583
  • [40] Alterations of the tumor suppressor genes CDKN2A (p16INK4a), p14ARF, CDKN2B (p15INK4b), and CDKN2C (p18INK4c) in atypical and anaplastic meningiomas
    Boström, J
    Meyer-Puttlitz, B
    Wolter, M
    Blaschke, B
    Weber, RG
    Lichter, P
    Ichimura, K
    Collins, VP
    Reifenberger, G
    AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (02): : 661 - 669
12345